Abraxis BioScience Joins Dossia Founders Group

PORTLAND, Ore.--(BUSINESS WIRE)--Dossia today announced Abraxis BioScience Inc. as the newest member of the Dossia Founders Group, joining eight major U.S. employers dedicated to empowering employees to make smarter, more informed decisions about their healthcare. The Dossia Founders include Applied Materials, AT&T, BP America, Cardinal Health, Intel, Pitney Bowes, sanofi-aventis and Wal-Mart.

“As the U.S. healthcare system moves toward a future that is increasingly electronic and online, major employers are in a position to collaborate and support employees and consumers”

Dossia’s primary goal is to create a Web-based infrastructure for the storing and managing of each employee’s health information via private and portable electronic health records. Through Dossia, employers are able to break down barriers to health information and help their employees to drive consumer-initiated change.

“I am delighted for Abraxis to be a part of Dossia’s mission to bring powerful healthcare tools to consumers,” said Patrick Soon-Shiong, MD, Chairman and Chief Executive Officer of Abraxis BioScience and founder of the National Coalition of Health Integration (NCHI). “There is an urgent need to integrate health care data on a national scale to empower patients, providers, and payers with the information they need to ensure the best quality health care. Without an open infrastructure platform, data will be siloed off and oriented around the needs of institutions and enterprises rather than focused where it belongs - on the needs of patients. I am excited to join the Dossia board and look forward to working with its 5 million employees to facilitate the vision of delivering health data to all.”

“As the U.S. healthcare system moves toward a future that is increasingly electronic and online, major employers are in a position to collaborate and support employees and consumers,” said Colin Evans, President and CEO of Dossia. “We are pleased to have Abraxis BioScience on board as a Dossia Founder and anticipate a strong relationship focused on healthcare transformation by enabling consumers to access their own data.”

Dossia was created to provide employees with access to and control over their personal health information. In September 2008, Dossia and Wal-Mart embarked on a major deployment of personally-controlled health records (PCHRs) to thousands of Wal-Mart Associates. Through the Dossia system, Associates have access to, and control over their lifelong, personal, private and portable health information. This inaugural deployment was the first step in a series of milestones that Dossia has under way with all of the Founders to help connect employees to their health information, enabling them to become agents for change in their own lives.

About Abraxis BioScience, Inc.

Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. The company's portfolio includes the world's first and only protein-bound nanoparticle chemotherapeutic compound (ABRAXANE), which is based on the company's proprietary tumor targeting technology known as the nab^(R) platform. The first FDA approved product to use this nab^(R) platform, ABRAXANE, was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on the NASDAQ Global Market under the symbol ABII. For more information about the company and its products, please visit www.abraxisbio.com.

About Dossia

Dossia is a non-profit organization consisting of several large U.S. employers who have united under a common vision: to empower their employees to make smarter more informed decisions about their healthcare. Through Dossia, they will leverage their combined influence to break down barriers to health information, which will help drive consumer-initiated change. The Dossia Founders group includes AT&T, Applied Materials, BP America, Cardinal Health, Intel, Pitney Bowes, sanofi-aventis and Wal-Mart. For more information, visit www.dossia.org.